| 000 | 01620 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515034331.0 | ||
| 264 | 0 | _c20060919 | |
| 008 | 200609s 0 0 eng d | ||
| 022 | _a0004-3591 | ||
| 024 | 7 |
_a10.1002/art.22019 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRoll, Petra | |
| 245 | 0 | 0 |
_aRegeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis. _h[electronic resource] |
| 260 |
_bArthritis and rheumatism _cAug 2006 |
||
| 300 |
_a2377-86 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 |
_aAntigens, CD _xanalysis |
| 650 | 0 | 4 |
_aAntigens, CD20 _ximmunology |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 |
_aB-Lymphocyte Subsets _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLymphocyte Depletion |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRegeneration _xdrug effects |
| 650 | 0 | 4 |
_aRheumatology _xmethods |
| 650 | 0 | 4 | _aRituximab |
| 700 | 1 | _aPalanichamy, Arumugam | |
| 700 | 1 | _aKneitz, Christian | |
| 700 | 1 | _aDorner, Thomas | |
| 700 | 1 | _aTony, Hans-Peter | |
| 773 | 0 |
_tArthritis and rheumatism _gvol. 54 _gno. 8 _gp. 2377-86 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/art.22019 _zAvailable from publisher's website |
| 999 |
_c16458299 _d16458299 |
||